Johan Richter
Lunds Universitet
H-index: 47
Europe-Sweden
Top articles of Johan Richter
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
Annals of Hematology
2023/6
Satu Mustjoki
H-Index: 41
Johan Richter
H-Index: 29
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
The Journal of clinical investigation
2022/9/1
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide …
American Journal of Hematology
2022/4
Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study
European journal of haematology
2021/12
Johan Richter
H-Index: 29
Satu Mustjoki
H-Index: 41
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI
Leukemia
2021/8
Johan Richter
H-Index: 29
Kourosh Lotfi
H-Index: 14
Anders Själander
H-Index: 22
Stefan Deneberg
H-Index: 12
Successful tyrosine kinase inhibitor discontinuation outside clinical trials—data from the population‐based Swedish chronic myeloid leukaemia registry
British journal of haematology
2021/6
Fredrik Sandin
H-Index: 12
Torsten Dahlén
H-Index: 5
Anders Själander
H-Index: 22
Johan Richter
H-Index: 29
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal
2021/3/12
Johan Richter
H-Index: 29
Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells
Stem cell research & therapy
2020/12
Johan Richter
H-Index: 29
Niels-Bjarne Woods
H-Index: 14
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
haematologica
2020/8
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020/4
Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy
Leukemia Research
2020/3/1
Johan Richter
H-Index: 29
Satu Mustjoki
H-Index: 41
Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case–Control Study
Cancer Epidemiology, Biomarkers & Prevention
2020/1/1
Johan Richter
H-Index: 29
Anders Själander
H-Index: 22
Co-Authors
